Natco Pharma’s Q1 net down 57% at ₹206 crore; to raise ₹2,000 crore
· thehindubusinessline.com
Revenue stood at ₹794 crore marking a decline of 43% in the quarter under review as against ₹1,390 crore for the corresponding quarter last year.
Natco Pharma’s consolidated net profit declined 57 per cent at ₹206 crore in the first quarter ended June 30, 2026, compared to ₹480 crore for the corresp...